InvestorsObserver
×
News Home

Is Crinetics Pharmaceuticals Inc (CRNX) Stock About to Get Hot Tuesday?

Tuesday, November 28, 2023 11:41 AM | InvestorsObserver Analysts

Mentioned in this article

Is Crinetics Pharmaceuticals Inc (CRNX) Stock About to Get Hot Tuesday?

Overall market sentiment has been high on Crinetics Pharmaceuticals Inc (CRNX) stock lately. CRNX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Crinetics Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CRNX!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With CRNX Stock Today?

Crinetics Pharmaceuticals Inc (CRNX) stock has fallen -0.9% while the S&P 500 has gained 0.37% as of 11:40 AM on Tuesday, Nov 28. CRNX is down -$0.28 from the previous closing price of $31.81 on volume of 97,587 shares. Over the past year the S&P 500 is higher by 15.22% while CRNX has gained 85.14%. CRNX lost -$3.64 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Crinetics Pharmaceuticals Inc click here.

More About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App